SIGLEC1 and psoriasis: These results suggest that CD169+ and CD169− skin macrophages exhibit distinct responses to IMQ stimulation, and that the unique upregulated genes in IMQ-treated CD169+ skin macrophages may be the key to their function in psoriasis.